AzTrials
AzTrials

Anxiety SymptomsTAPNCT03659591

Triple Aim Psychotherapy: Aimed at Improving Patient Experience, Population Health, and Cost

A study testing Cognitive Behaviour Therapy and Adaptive Psychological Training in people with Anxiety Symptoms and Depressive Symptoms, run by Joseph Brant Hospital at 1 site in Canada.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Community mental health programs in publically-funded jurisdictions such as Canada often have limited budgets in order to provide services, which can result in inadequate access to effective treatment for patients. Cognitive Behaviour Therapy (CBT) is a gold-standard psychotherapy for depression and anxiety. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Anxiety Symptoms, Depressive Symptoms
What is being tested?
Cognitive Behaviour Therapy and Adaptive Psychological Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteCanada
Study dates
Sep 2018to Nov 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Treatment-seeking adults, interested and willing to participate in group psychotherapy
  • Mild-to-moderate depressive (score of ≥10 and <20 on PHQ9) and/or anxious (score of ≥8 and <15 on GAD7) symptoms
  • Ability to communicate, in written and spoken English

Who cannot join

  • Severe depressive/anxious symptoms
  • Patients where the primary clinical focus is active suicidality or harm-to-others, psychosis, mania, substance use, posttraumatic stress, or personality pathology such that it would interfere with group function
  • Recent course(s) of the study psychotherapies

Trial locations and contacts

1 site in 1 country.

Steven Selchen, MD MSt FRCPC contact

(905) 681-4812

dr.steven.selchen@josephbranthospital.ca

Benjamin D Diplock, BScH contact

ben.diplock@sunnybrook.ca

Canada1 site
  • Joseph Brant Hospital

    Burlington, Ontario, L7S OA2

    Steven Selchen, MD MSt FRCPC, (905) 681-4812, dr.steven.selchen@josephbranthospital.ca

Other trials in Canada

About this study

Official title: Triple Aim Psychotherapy: an RCT Comparing Cognitive Behaviour Therapy (CBT) to Adaptive Psychological Training (APT) - a Treatment Aimed at Improving Patient Experience, Population Health, and Cost-effectiveness

Community mental health programs in publically-funded jurisdictions such as Canada often have limited budgets in order to provide services, which can result in inadequate access to effective treatment for patients. Cognitive Behaviour Therapy (CBT) is a gold-standard psychotherapy for depression and anxiety. In order to improve access to treatment, community mental healthcare settings often provide CBT in a group format for patients experiencing mild-to-moderate symptoms. However, typical protocols for delivering group CBT in a community setting nonetheless require a considerable investment of limited clinician time. The Institute for Healthcare Improvement (IHI) developed the Triple Aim, which is a framework describing an approach to optimizing health system performance by simultaneously pursuing three dimensions, namely improving the patient experience of care; improving the health of populations; and reducing the associated per capita costs of care. Adaptive Psychological Training (APT) is a group-based psychotherapy designed with all of the dimensions of the Triple Aim in mind simultaneously. In its development, APT drew heavily upon mindfulness-based approaches. To-date, APT has already demonstrated positive outcomes in pilot research and in community clinical settings. The purpose of the current study is to determine whether for a given population of patients experiencing mild-to-moderate symptoms of depression and/or anxiety, APT can facilitate meaningful change for more patients per time spent by clinicians than can CBT.

Read the detailed description

Depression and anxiety are highly prevalent in the general population. Community mental health programs in publically-funded jurisdictions such as Canada often have relatively limited, fixed budgets in order to provide services, which can result in inadequate access to effective treatment for patients. Cognitive Behaviour Therapy (CBT) is a gold-standard psychotherapeutic treatment for depression and anxiety. In order to improve access to treatment, community mental healthcare settings often provide CBT in a group format for patients experiencing mild-to-moderate symptoms. However, typical protocols for delivering group CBT in a community setting nonetheless require a considerable investment of limited clinician time.

The question arises as to whether this is the most efficient and effective use of clinician time; in other words, per hour spent of clinician time, does this approach maximize the number of patients experiencing adequate and meaningful clinical improvement? The Institute for Healthcare Improvement (IHI) developed the Triple Aim, which is a framework describing an approach to optimizing health system performance by simultaneously pursuing three dimensions, namely improving the patient experience of care; improving the health of populations; and reducing the associated per capita costs of care. Studies of psychotherapy rarely pursue all three of these dimensions simultaneously. Efforts to achieve the best clinical outcome for an individual often lead to restrictive inclusionary/exclusionary criteria that sacrifice reaching the wider population; conversely, efforts to improve population health often prioritize composite overall clinical improvement across an entire group, even though the change experienced by many of the individuals in the population might not be clinically meaningful; focusing primarily on cost-effectiveness often sacrifices the individual's experience and/or the population's needs.

Adaptive Psychological Training (APT) is a group-based psychotherapy designed with all of the dimensions of the Triple Aim in mind simultaneously. In its development, APT drew heavily upon Mindfulness-Based Cognitive Therapy, an evidence-based psychotherapy that itself draws upon both evidence-based eastern psychotherapeutic practices and CBT, but APT also drew upon other evidence-based and evidence-supported psychotherapies including interpersonal and relational approaches, as well as meaning-focused psychoanalytic models. It also drew from psychology and neuroscience more broadly, as well as from learning theory and from practical clinical and operational experience. Inclusion/exclusion criteria, group size, number of sessions, in-session practice and learning, and between-session practice and learning were all adapted from the perspective of trying to achieve high quality outcomes for a broader population within more contained costs, and thereby increase access to quality care.

To-date, APT has already demonstrated positive outcomes in pilot research and in community clinical settings. The purpose of this specific study is to determine whether for a given population of patients experiencing mild-to-moderate symptoms of depression and/or anxiety, APT can facilitate meaningful change for more patients per time spent by clinicians than can CBT (the gold standard). The significance of this study includes its potential contribution to determining how best to deploy the limited resource of clinician time in a community setting in order to best help the most people.

Being tested
Cognitive Behaviour Therapy, Adaptive Psychological Training
Keywords
Cognitive Behaviour Therapy, Community Mental Health, Adaptive Psychological Training, Quality of Life, Wellbeing, Treatment
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive Behaviour TherapyBehavioural

    Also called CBT

    CBT will be delivered in group format, consisting of 10 weekly two-hour sessions, with 10 participants per group

  • Adaptive Psychological TrainingBehavioural

    Also called APT

    APT will be delivered in group format, consisting of 5 weekly two-hour sessions, with 20 participants per group

Study groups in NCT03659591
Study groupRoleWhat they receive
Cognitive Behaviour TherapyActive comparator10 week, manual-based group CBT treatment for depression and anxiety, followed by optional booster sessions
Receives: Behavioral: Cognitive Behaviour Therapy
Adaptive Psychological TrainingActive comparator5 week, manual-based group APT treatment for depression and anxiety, followed by optional booster sessions
Receives: Behavioral: Adaptive Psychological Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Triple Aim Measure

    Numerator: The number of patients achieving reliable recovery; denominator: clinician time spent in hours ('reliable recovery' is defined as scores below 'caseness' for both depression [<10 on Patient Health Questionnaire (PHQ-9)] and anxiety [<8 on Generalized Anxiety Disorder-7 (GAD-7)], with any change from above caseness to below caseness meeting the threshold of the Reliable Change Index)

    Measured: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months

Secondary outcomes (7)
  1. Triple Aim Measure - recovery only

    Triple Aim Composite Score (as above), but without the Reliable Change Index requirement

    Measured: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months

  2. Triple Aim Measure - improvement only

    Triple Aim Composite Score (as above), but without the remission requirement

    Measured: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months

  3. Change from baseline - depressive symptoms

    Scale used to measure depressive symptoms is the Patient Health Questionnaire (PHQ-9); score ranges from 0-27, where higher values indicate more depressive symptoms (worse outcome)

    Measured: Pre- (week 0) and repeated every two weeks across 6 months

  4. Change from baseline - anxiety symptoms

    Scale used to measure anxiety symptoms is the Generalized Anxiety Disorder 7-item (GAD-7) Scale; score ranges from 0-21, where higher values indicate more anxiety symptoms (worse outcome)

    Measured: Pre- (week 0) and repeated every two weeks across 6 months

  5. Change from baseline - function

    Scale used to measure function is the World Health Organization Disability Assessment Schedule 2.0 - 12 item version (WHODAS 2.0 12-item); score ranges from 0-48, where higher values indicate lower functioning (worse outcome)

    Measured: Pre- (week 0) and repeated monthly across 6 months

  6. Change from baseline - mental wellbeing

    Scale used to measure mental wellbeing is the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS); score ranges from 14-70, where higher values indicate greater mental wellbeing (better outcome)

    Measured: Pre- (week 0) and repeated monthly across 6 months

  7. Change from baseline - self-compassion

    Scale used to measure self-compassion is the Self-Compassion Scale - Short Form (SCS-SF); score ranges from 12-60, where higher values indicate greater self-compassion (better outcome)

    Measured: Pre- (week 0) and repeated monthly across 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Sep 2018
  2. Study startSep 2018 (estimated)
  3. Primary completionAug 2019 (estimated)
  4. Study completionNov 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03659591
Sponsor's protocol ID
000-044-18
Acronym
TAP
Status last verified
Sep 2018
First submitted
30 Aug 2018
Last updated
6 Sep 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive Behaviour Therapy and Adaptive Psychological Training in people with Anxiety Symptoms and Depressive Symptoms, run by Joseph Brant Hospital at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 6 Sep 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Steven Selchen, MD MSt FRCPC ((905) 681-4812, dr.steven.selchen@josephbranthospital.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Triple Aim Measure (time frame: At 10 weeks; in a secondary fashion, this outcome will also be examined every two weeks across 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Sep 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in